World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
40551
World Ranking
12938
National Ranking
6615

Paul E. Goss publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paul E. Goss sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 447 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Paul E. Goss D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paul E. Goss sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Paul E. Goss is affiliated with Harvard University in the United States. Their research primarily falls within the field of Medicine, with a focus on Oncology and related subfields such as Reproductive Medicine, Genetics, Cancer Research, and Statistics and Probability.

The topics of their work cover areas including ovarian cancer diagnosis and treatment, cancer risks and factors, global cancer incidence and screening, estrogen and related hormone effects, breast cancer treatment studies, statistical methods in clinical trials, and medical imaging techniques and applications.

Paul E. Goss has contributed to several publications, notably:

  • Panorama of Gynecologic Cancer in Brazil, 2020, JCO Global Oncology
  • Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole, 2024, Journal of Clinical Oncology
  • Adjunctive statistical standardization of quantitated adjuvant ER and PgR in CCTG MA.27., 2024, Journal of Clinical Oncology
  • Abstract P1-07-06: Adjunctive statistical standardization of quantitated adjuvant HER2 and very low statistically standardized HER2 in CCTG MA.27, 2025, Clinical Cancer Research

The venues in which Paul E. Goss frequently publishes include the Journal of Clinical Oncology, JCO Global Oncology, and Clinical Cancer Research.

Frequent co-authors collaborating with Paul E. Goss are:

  • Jane Bayani
  • Sandip Sengupta
  • Tammy Piper
  • Mary Anne Quintayo
  • Shakeel Virk

Best Publications

  • Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    A Goldhirsch;E P Winer;A S Coates;R D Gelber

  • A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer

    Paul E. Goss;James N. Ingle;Silvana Martino;Nicholas J. Robert

  • Breast cancer in China

    Lei Fan;Lei Fan;Kathrin Strasser-Weippl;Jun Jie Li;Jun Jie Li;Jessica St Louis

  • Estrogen and the Risk of Breast Cancer

    Mark Clemons;Paul Goss

  • Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials

    Colin Baigent;N. Bhala;J. Emberson;A. Merhi

  • Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17

    Paul E. Goss;James N. Ingle;Silvana Martino;Nicholas J. Robert

  • Exemestane for Breast-Cancer Prevention in Postmenopausal Women

    Paul E. Goss;James N. Ingle;José E. Alés-Martínez;Angela M. Cheung

  • Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

    Paul E. Goss;James N. Ingle;Kathleen I. Pritchard;Nicholas J. Robert

  • Planning cancer control in Latin America and the Caribbean

    Paul E. Goss;Brittany L. Lee;Brittany L. Lee;Tanja Badovinac-Crnjevic;Kathrin Strasser-Weippl

  • Challenges to effective cancer control in China, India, and Russia

    Paul E. Goss;Kathrin Strasser-Weippl;Brittany L. Lee-Bychkovsky;Brittany L. Lee-Bychkovsky;Lei Fan;Lei Fan

  • Inhibitors of carbohydrate processing: A new class of anticancer agents.

    Paul E Goss;Michael A. Baker;Jeremy P. Carver;James W. Dennis

  • Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

    Ellen Warner;William Foulkes;Pamela Goodwin;Wendy Meschino

  • Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer

    Nadine Tchen;Helen G. Juffs;Fiona P. Downie;Qi-Long Yi

  • Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population

    Dennis C Sgroi;Ivana Sestak;Jack Cuzick;Yi Zhang

  • Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials: The Cross Trial Safety Analysis

    Scott D. Solomon;Janet Wittes;Peter V. Finn;Robert Fowler

  • Physical and Psychological Morbidity After Axillary Lymph Node Dissection for Breast Cancer

    Thomas F. Hack;Lorenzo Cohen;Joel Katz;Lynda S. Robson

  • TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

    Steven J. Isakoff;Erica L. Mayer;Lei He;Tiffany A. Traina

  • Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996.

    Paul E. Goss;Caroline Reid;Melania Pintilie;Ruth Lim

  • Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer

    Lilian U. Thompson;Jian Min Chen;Tong Li;Kathrin Strasser-Weippl

  • Aromatase inhibitors in the treatment and prevention of breast cancer

    Paul E. Goss;Kathrin Strasser

Frequent Co-Authors

Kathleen I. Pritchard
Kathleen I. Pritchard University of Toronto
James N. Ingle
James N. Ingle Mayo Clinic
Dianne M. Finkelstein
Dianne M. Finkelstein Harvard University
Timothy J. Whelan
Timothy J. Whelan McMaster University
Karen A. Gelmon
Karen A. Gelmon University of British Columbia
Dennis C. Sgroi
Dennis C. Sgroi Harvard University
Dongsheng Tu
Dongsheng Tu Queen's University
Matthew J. Ellis
Matthew J. Ellis Baylor College of Medicine
Aman U. Buzdar
Aman U. Buzdar The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career doesn’t always require following the traditional path of becoming an MD. For those seeking flexibility or wanting to enter the workforce sooner, numerous related online degrees and career pathways are available.

Many students begin by looking into nursing. If you want a more accessible entry, check out the easiest rn program options that offer less competitive admissions. For those aiming to skip certain pre-admission exams, consider absn programs that don't require teas. These options can accelerate your transition into nursing.

Prefer a non-clinical healthcare role? Training in medical billing and coding is a great alternative, especially for those interested in healthcare administration and technology. Explore medical billing and coding schools that accept financial aid to find programs that support your educational journey.

For career advancement, consider a healthcare administration online degree. This field offers broad opportunities to lead and manage within healthcare systems.

Best Scientists Citing Paul E. Goss

Trending Scientists

Recently Published Articles